Oranges And Tangerines Can Help Reduce Risk Of Obesity, Heart Disease, And Diabetes

March 6, 2020

Including plenty of fruits and vegetables in your diet can help keep you healthy, but a recent study shows that one particular type of fruit could be more beneficial than previously thought.

Researchers from Western University say that a molecule called nobiletin that is found in oranges and tangerines can help reverse negative symptoms linked to obesity, heart disease, and diabetes. The team believes that their findings could be good news for health care providers who are always looking for new ways to promote better health.

“Obesity and its resulting metabolic syndromes are a huge burden to our health care system, and we have very few interventions that have been shown to work effectively,” said Dr. Murray Huff. “We need to continue this emphasis on the discovery of new therapeutics.”

Leaner and healthier

The researchers came to their conclusions after studying mice who were fed a diet high in fat and cholesterol. While some of the mice were only given foods high in these substances, others were also given nobiletin.

After observing the physical changes in the mice over time, the team concluded that the mice that also received nobiletin were leaner and had lower levels of insulin resistance and blood fats when compared to the control mice. Huff says that these results strongly suggest that nobiletin can be used as a health intervention.

“We’ve shown that in mice that already have all the negative symptoms of obesity, we can use nobiletin to reverse those symptoms, and even start to regress plaque build-up in the arteries, known as atherosclerosis,” he said.

By submitting this form, you are consenting to receive marketing emails from: Harlem World Magazine, 2521 1/2 west 42nd street, Los Angeles, CA, 90008, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

The team hopes to continue their research with human trials to see if nobiletin has the same effect on people. The full study has been published in the Journal of Lipid Research reports Consumer Affairs.

We're your source for local coverage, we count on your support. SPONSOR US!
Your support is crucial in maintaining a healthy democracy and quality journalism. With your contribution, we can continue to provide engaging news and free access to all.
accepted credit cards

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles